Courtney Young, PhD, on Gene Editing Approaches to Treating Neuromuscular Disease
The co-founder and chief executive officer of MyoGene Bio spoke about the company's gene editing therapy for Duchenne muscular dystrophy at MDA’s 2023 conference.